Business Context and Reporting Period
This Form 8-K is a current report filed by PharmAthene, Inc. (not Altimmune, Inc.) on November 11, 2010. The filing serves to announce the company's financial and operational results for the quarter ended September 30, 2010. The registrant is incorporated in Delaware and maintains its principal executive offices in Annapolis, Maryland.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the detailed financial results are contained within a press release furnished as Exhibit 99.1, which is not included in the input text. Consequently, no specific financial metrics can be extracted from this document alone.
Material Changes
The filing does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of a press release detailing the results for the quarter ended September 30, 2010.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, or specific risk factors. It includes a standard legal disclaimer stating that the information in this Current Report, including the referenced press release, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly set forth.
Investor Verification Checklist
- Verify the correct registrant name: The filing is for PharmAthene, Inc., not Altimmune, Inc.
- Locate and review Exhibit 99.1 (the press release dated November 11, 2010) to obtain actual financial figures for the quarter ended September 30, 2010.
- Confirm the company's current status, as this filing is from 2010 and the company may have undergone name changes, mergers, or delistings since then.
- Note that the financial data in this specific 8-K text is not legally "filed" under Section 18 of the Exchange Act.